Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocular Therapeutix (OCUL) Long-Term Debt Issuances (2017 - 2019)

Historic Long-Term Debt Issuances for Ocular Therapeutix (OCUL) over the last 2 years, with Q2 2019 value amounting to -$70000.0.

  • Ocular Therapeutix's Long-Term Debt Issuances changed N/A to -$70000.0 in Q2 2019 from the same period last year, while for Sep 2021 it was -$70000.0, marking a year-over-year change of. This contributed to the annual value of $82.5 million for FY2023, which is N/A changed from last year.
  • Ocular Therapeutix's Long-Term Debt Issuances amounted to -$70000.0 in Q2 2019.
  • In the past 5 years, Ocular Therapeutix's Long-Term Debt Issuances registered a high of $37.3 million during Q1 2019, and its lowest value of -$70000.0 during Q2 2019.